Canada markets closed

Telomir Pharmaceuticals, Inc. (TELO)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
5.70-0.35 (-5.79%)
At close: 04:00PM EDT
6.01 +0.31 (+5.44%)
After hours: 07:17PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 178.84M
Enterprise Value 178.94M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)59.29
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 320.80%
S&P500 52-Week Change 328.04%
52 Week High 320.72
52 Week Low 34.76
50-Day Moving Average 36.62
200-Day Moving Average 37.18

Share Statistics

Avg Vol (3 month) 345.03k
Avg Vol (10 day) 327k
Shares Outstanding 529.61M
Implied Shares Outstanding 629.61M
Float 816.54M
% Held by Insiders 142.48%
% Held by Institutions 10.23%
Shares Short (Apr 30, 2024) 429.87k
Short Ratio (Apr 30, 2024) 40.54
Short % of Float (Apr 30, 2024) 40.18%
Short % of Shares Outstanding (Apr 30, 2024) 40.10%
Shares Short (prior month Mar 28, 2024) 415.71k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-102.18%
Return on Equity (ttm)-1,045.36%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-13.07M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.23k
Total Cash Per Share (mrq)0
Total Debt (mrq)628.38k
Total Debt/Equity (mrq)18.28%
Current Ratio (mrq)0.33
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-3.86M
Levered Free Cash Flow (ttm)-1.96M